ADPEAF is a benign syndrome in the great majority of individuals. No clinical trials of different antiepileptic medications have been carried out, but most individuals have been readily able to achieve seizure control with medications used routinely in clinical practice (e.g., carbamazepine, phenytoin, valproate).
